Age Demographics of Subjects Enrolled in Global, Interventional Phase 3 Melanoma Clinical Trials

BACKGROUND: Melanoma is a skin cancer with a rising worldwide incidence of just over 280,000 individuals with the greatest burden of illness in European, New Zealander, and Australian populations. Patients are diagnosed with melanoma with the mean and median ages being 65 and 59 years old, respectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Reema, Patel, Nil, Patel, Yasha, Toscani, Michael, Barone, Joseph, Weber, Paul F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854139/
https://www.ncbi.nlm.nih.gov/pubmed/35001359
http://dx.doi.org/10.1007/s43441-021-00362-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854139/
https://www.ncbi.nlm.nih.gov/pubmed/35001359
http://dx.doi.org/10.1007/s43441-021-00362-0

Ejemplares similares